Purchase Order 75N98026P00833
Award Date 8/1/26
Potential Completion Date 7/31/27
Potential Value $80K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Spain
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Cyclope Bio SL for $140,000.00 on September 11, 2025, for the supply of enantiomers of cyclopentanediamine and tetrahydrofurandiamine, with an ultimate completion date of September 10, 2026. The order covers ongoing collaboration to purchase specialized chemical compounds (100 grams each of three distinct enantiomers) and research services to develop routes to pyrrolidine analogs in support of...
- This is a $36,000.00 firm fixed-price contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which is part of the National Institutes of Health (NIH), a civilian agency. The contract was awarded to Entrechem SL, a for-profit manufacturer located in Spain, to provide 100g each of two specialized chemical compounds, (1S,2S)-trans-N-Boc-Tetrahydro-3,4-furandiamine and (1R,2R)-trans-N-Boc-Tetrahydro-3,4-furandiamine. These compounds are needed as starting...
- This federal contract award, valued at $50,000.00, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services, to the prime contractor Entrechem SL. The contract is for the purchase of 100 grams each of two specific enantiomers of trans-N-Boc-1,2-tetrahydro-3,4-furandiamine. These chemical compounds are needed as starting materials for the NIDDK's research into developing thyclotides, which...
- This is a $10,585.00 firm fixed price purchase order awarded by the National Heart Lung and Blood Institute, a civilian agency, to Bio-Synthesis, Inc., a Hispanic American-owned manufacturer of goods. The contract is for the delivery of stapled NIX-derived peptides with derivatized N-termini to support the agency's ongoing study of the NIX/WIPI protein interaction, which began in March 2023. The award does not utilize a set-aside designation, and the ultimate completion date is June 24, 2025.
- The National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $237,922.80 firm fixed price purchase order to Pine Pharmaceuticals LLC. The purpose of this acquisition is to procure an intravenous stable isotope to support metabolic research studies being conducted by the funding agency. The solicitation sought a stable isotope that meets NIH specifications for use in clinical human research, referencing a history of safe use in such studies. No...
- This contract was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Government Scientific Source Inc. (GSS) on July 8, 2015 for the delivery of (1R, 2R) cyclopentanediamine, a chemical product. The contract was a firm fixed-price purchase order with a ceiling value of $6,078.45. There was no set-aside designation. GSS is a leading distributor of laboratory products and equipment, providing a variety of scientific products and...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to A & A Labs LLC, doing business as Synthetic Biomolecules. The $8,482.00 contract is for the custom synthesis of 15-mer peptides. The contract is set aside for small businesses and the awardee is a minority-owned, self-certified small disadvantaged business. The place of performance is San Diego,...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences awarded a $19,800 firm fixed price purchase order to Karebay Biochem Inc., a for-profit small business, to synthesize 200 grams of compound NCGC00413972. This order supports NIH's biomedical research programs, particularly in the areas of drug discovery and infectious disease. Karebay Biochem has received multiple prior purchase orders from NIH entities to...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $37,000.00 Firm Fixed Price purchase order to Polyorg, Inc., a for-profit manufacturer located in Leominster, Massachusetts. The contract is for the procurement of Bhoc Nucleobase Acids to support NIDDK's biomedical research. This award was made without competition under the original Request for Quotation (RFQ) number 75N94023Q00088, which had a NAICS code of 541380 with a $19 million size standard. No...
- <p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation valued at $81,885.40 on June 22, 2018, with ultimate completion on December 21, 2018. No set-aside was used. Place of performance is Bethesda, Maryland. The purchase order was a firm fixed price acquisition for scientific instruments, reagents, or consumables typical of Life Technologies' federal supply portfolio supporting research and diagnostic missions.</p>